Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nuria Maria Asensio Sierra"'
Autor:
Elisabetta Bertocchi, Luca Braglia, Giovanna Artioli, Elisa Rabitti, Nuria Maria Asensio Sierra, Massimo Costantini, Silvia Di Leo, Gabriele Bedini
Publikováno v:
BMJ supportivepalliative care.
BackgroundQuality of care for patients dying in hospital remains suboptimal. A major problem is the identification of valid sources of information about the views and experiences of dying patients and their relatives.AimThis study aimed to estimate t
Autor:
Maria, Pagano, Nuria Maria Asensio, Sierra, Michele, Panebianco, Giulio, Rossi, Roberta, Gnoni, Giancarlo, Bisagni, Corrado, Boni
Publikováno v:
Anticancer research. 34(9)
To retrospectively evaluate sorafenib activity and safety in patients with metastatic thymic carcinoma (TC) and to correlate outcome with c-KIT and PDGFR-alpha mutational status.Patients with metastatic thymic carcinoma treated with sorafenib after a
Autor:
Corrado, Boni, Maria, Pagano, Michele, Panebianco, Alessandra, Bologna, Nuria Maria Asensio, Sierra, Roberta, Gnoni, Debora, Formisano, Giancarlo, Bisagni
Publikováno v:
Anticancer research. 34(3)
Hormone therapy plays an important role in the management of breast cancer. In the past, testosterone was the most common line of hormonal therapy for this disease, but its use has been almost completely abandoned in the past 40 years. However, becau
Autor:
M. Perrone, Claudio Zamagni, Pierandrea De Iaco, Giorgia Zucchini, Elena Barbieri, Martino Abrate, Daniela Rubino, Alessandra Bologna, Nuria Maria Asensio Sierra, Marta Cubelli, Vincenzo Dario Mandato
Publikováno v:
Publons
TPS5624 Background: The role and the duration of neoadjuvant chemotherapy (NACT) in advanced epithelial ovarian cancer (AOC) are still debated. A phase III randomized trial showed that 3 courses of...
Autor:
Sandro Pignata, Giovanni Scambia, Rossella Lauria, Francesco Raspagliesi, Pierluigi Benedetti Panici, Gennaro Cormio, Dionyssios Katsaros, Roberto Sorio, Giovanna Cavazzini, Gabriella Ferrandina, Enrico Breda, Viviana Murgia, Cosimo Sacco, Nuria Maria Asensio Sierra, Carmela Pisano, Vanda Salutari, Beatrice E. Weber, Eric Pujade-Lauraine, Ciro Gallo, Francesco Perrone
Publikováno v:
Journal of Clinical Oncology. 31:LBA5501-LBA5501
LBA5501 Background: Three-weekly (3w) CP is standard first-line chemotherapy for AOC pts. Weekly (w) P combined with 3w C prolonged PFS and OS in a JGOG phase III trial. MITO-7 is an academic randomized phase III study, comparing 3w vs. w CP. Methods
Autor:
Francesco Perrone, Giovanni Scambia, Roberto Sorio, Béatrice Weber, Sandro Pignata, Gennaro Cormio, Gabriella Ferrandina, Cosimo Sacco, Rossella Lauria, Vanda Salutari, Dionyssios Katsaros, Nuria Maria Asensio Sierra, Enrico Breda, Carmela Pisano, Eric Pujade-Lauraine, Giovanna Cavazzini, Pierluigi Benedetti Panici, Ciro Gallo, Francesco Raspagliesi, V. Murgia
Publikováno v:
Publons
LBA5501 Background: Three-weekly (3w) CP is standard first-line chemotherapy for AOC pts. Weekly (w) P combined with 3w C prolonged PFS and OS in a JGOG phase III trial. MITO-7 is an academic randomized phase III study, comparing 3w vs. w CP. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0168bfdf06cbb5e5e5c0886eddf2a4e
https://publons.com/publon/26575798/
https://publons.com/publon/26575798/